-transparent.png){kind=logo}
In a double-masked, 3-month clinical study the ocular hypotensive effects of diacetyl nadolol (DAN), timolol, and nadolol were compared. When applied topically to the eyes of glaucomatous patients timolol 0.5% was found to be significantly more effective than DAN 2% in controlling IOP at 3 of 10 evaluation periods. Fewer patients, however, developed tolerance to DAN 2% than to timolol 0.5%. DAN 0.5% was also effective in lowering intraocular pressure in 3 of 8 patients tested. Nadolol 2% had no long-term ocular hypotensive effect. Two of 8 patients treated with DAN 2% developed a bilateral periorbital dermatitis and were removed from the study even though their intraocular pressures were well controlled. No other clinically significant local or systemic side effects were observed during the course of the study.
E Duzman, and
N Rosen, and
M Lazar
December 1982,
Archives of ophthalmology (Chicago, Ill. : 1960),
E Duzman, and
N Rosen, and
M Lazar
January 1987,
Journal of ocular pharmacology,
E Duzman, and
N Rosen, and
M Lazar
January 1982,
Nippon Ganka Gakkai zasshi,
E Duzman, and
N Rosen, and
M Lazar
May 1963,
Rinsho ganka. Japanese journal of clinical ophthalmology,
E Duzman, and
N Rosen, and
M Lazar
January 2008,
Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists),
E Duzman, and
N Rosen, and
M Lazar
December 1980,
Polskie Archiwum Medycyny Wewnetrznej,
E Duzman, and
N Rosen, and
M Lazar
December 2000,
Journal of glaucoma,
E Duzman, and
N Rosen, and
M Lazar
January 1962,
American journal of ophthalmology,
E Duzman, and
N Rosen, and
M Lazar
December 1987,
Journal of pharmaceutical sciences,
E Duzman, and
N Rosen, and
M Lazar
November 2000,
Archivos de la Sociedad Espanola de Oftalmologia,
